Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2026 |
Sep. 30, 2025 |
Sep. 30, 2026 |
Sep. 30, 2025 |
|||||||||
| Investment Income | ||||||||||||
| Interest income | $ 1,851 | $ 2,409 | $ 6,280 | $ 4,525 | ||||||||
| Total Investment Income | 1,851 | 2,409 | 6,280 | 4,525 | ||||||||
| Expenses | ||||||||||||
| Organizational expenses | 0 | 0 | 0 | 7,784 | ||||||||
| Performance participation allocation | 12,101 | 10,194 | 13,123 | 17,407 | ||||||||
| General and administrative expenses | 2,190 | 2,035 | 6,100 | 4,882 | ||||||||
| Professional fees | 485 | 1,379 | 2,588 | 2,755 | ||||||||
| Management fees | 3,630 | 1,555 | 9,460 | 2,364 | ||||||||
| Deferred offering costs amortization | 0 | 376 | 374 | 660 | ||||||||
| Deferred financing costs amortization | 291 | 0 | 680 | 0 | ||||||||
| Directors' fees and expenses | 102 | 103 | 308 | 299 | ||||||||
| Interest expense | 1,015 | 0 | 2,547 | 0 | ||||||||
| Total Expenses | 19,814 | 15,642 | 35,180 | 36,151 | ||||||||
| Management fees waived | 0 | (1,555) | 0 | (2,364) | ||||||||
| Total Expenses after Fees Waived | 19,814 | 14,087 | 35,180 | 33,787 | ||||||||
| Net Investment Loss | (17,963) | (11,678) | (28,900) | (29,262) | ||||||||
| Net Realized and Unrealized Gain (Loss) on Investments | ||||||||||||
| Net realized gain on investments | 0 | 0 | 0 | 0 | ||||||||
| Net change in unrealized appreciation (depreciation) on investments | 59,746 | [1] | 66,526 | [1] | 101,851 | [1] | 113,717 | [2] | ||||
| Net Realized and Unrealized Gain (Loss) | 59,746 | 66,526 | 101,851 | 113,717 | ||||||||
| Net Increase / (Decrease) in Net Assets Resulting from Operations | 41,783 | 54,848 | 72,951 | 84,455 | ||||||||
| Net increase / (decrease) in net assets attributable to General Partner redeemable non-controlling interests in consolidated entities | 970 | 0 | 1,419 | 0 | ||||||||
| Net Increase / (Decrease) attributable to VistaOne, L.P. unitholders | $ 40,813 | $ 54,848 | $ 71,532 | $ 84,455 | ||||||||
| ||||||||||||
| X | ||||||||||
- Definition Deferred Financing Costs Amortization No definition available.
|
| X | ||||||||||
- Definition Deferred Offering Costs Amortization No definition available.
|
| X | ||||||||||
- Definition Net unrealized gain (loss) on investments. No definition available.
|
| X | ||||||||||
- Definition Performance Participation Allocation No definition available.
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, before investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of fee contractually waived by investment company. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after reimbursement and fee waiver, of expense for generation of investment income classified as operating. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount, before tax, of realized and unrealized gain (loss) on investment and derivative, classified as operating, and foreign currency transaction. Investment includes, but is not limited to, debt and equity securities, security sold short, real estate, and commodity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expenses related to the generation of investment income. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for investment management fee, including, but not limited to, expense in connection with research, selection, supervision, and custody of investment. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to redeemable noncontrolling interest. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for service provided by entity's director. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of expense for formation and organizational costs incurred to establish entity to do business. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of realized gain (loss) on investment. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of unrealized gain (loss) on investment. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|